Chronic Fatigue Syndrome: Clinical Trials

8 trials for Chronic Fatigue Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated, 1 withdrawn. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 6, Terminated 1, Withdrawn 1

Follow Chronic Fatigue Syndrome: new trials by email Literature Review of Chronic Fatigue Syndrome trials Research Report on Chronic Fatigue Syndrome

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compound Ciwujia Granules Treat Chronic Fatigue Syndrome
Compound Ciwujia Granules, Guipi Granules - Chronic Fatigue Syndrome
Phase 4CompletedHeilongjiang Quanle Pharmaceutical Co., Ltd.2352024-03-192025-09-23
A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Solriamfetol Oral Tablet [Sunosi], Placebo - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 4CompletedRochester Center for Behavioral Medicine442021-04-272025-04-06
SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE)
Sodium Oxybate, placebo (fresh potable water) - Chronic Fatigue Syndrome
Phase 4CompletedImperial College London132014-04-012020-11-18
Sodium Oxybate in Patients With Chronic Fatigue Syndrome.
Sodium oxybate, Placebo - Chronic Fatigue Syndrome
Phase 4WithdrawnUniversity Hospital, Ghent2013-06-012022-12-15
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
Lisdexamfetamine Dimesylate, Placebo "30, 50 or 70 mg" - Chronic Fatigue Syndrome, Cognitive Impairments
Phase 4CompletedRochester Center for Behavioral Medicine262009-11-012025-09-09
Giardia Induced Fatigue and Functional Gastrointestinal Diseases
Psycoeducation/counseling, Cognitive behavioural therapy - Chronic Fatigue Syndrome
Phase 4CompletedUniversity of Bergen402009-03-012017-03-03
Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
Placebo, Sodium Oxybate - Chronic Fatigue Syndrome
Phase 4TerminatedUniversity of Medicine and Dentistry of New Jersey172007-05-012016-05-19
Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
Sildenafil (Viagra), Placebo - Chronic Fatigue Syndrome
Phase 4CompletedCharles Drew University of Medicine and Science122002-07-012017-06-27

Narrower conditions

Fatigue Syndrome, Chronic (8)  ·  Fatigue (3)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Cognitive Dysfunction (1)  ·  Giardiasis (1)  ·  Pain (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Chronic Disease (8)  ·  Disease Attributes (8)  ·  Encephalomyelitis (8)  ·  Muscular Diseases (8)  ·  Musculoskeletal Diseases (8)  ·  Nervous System Diseases (8)  ·  Neuroinflammatory Diseases (8)  ·  Neuromuscular Diseases (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (3)  ·  Bronchial Diseases (2)  ·  Bronchiolitis (2)  ·  Bronchiolitis Obliterans (2)  ·  Bronchitis (2)

Interventions

Sodium Oxybate (3)  ·  Cognitive Behavioral Therapy (1)  ·  Counseling (1)  ·  Lisdexamfetamine Dimesylate (1)  ·  Sildenafil Citrate (1)  ·  Sugars (1)  ·  solriamfetol (1)

Sponsors

Rochester Center for Behavioral Medicine (2)  ·  Charles Drew University of Medicine and Science (1)  ·  Heilongjiang Quanle Pharmaceutical Co., Ltd. (1)  ·  Imperial College London (1)  ·  University Hospital, Ghent (1)  ·  University of Bergen (1)  ·  University of Medicine and Dentistry of New Jersey (1)

Countries

United States (4)  ·  Belgium (1)  ·  China (1)  ·  Norway (1)  ·  United Kingdom (1)

Top investigators

An Mariman, MD (1)  ·  Benjamin Natelson, MD (1)  ·  Bjarte Stubhaug, PhD (1)  ·  David Nutt, DM FRCPsych (1)  ·  Joel L. Young, M.D. (1)  ·  Joel Young, MD (1)  ·  Nina Langeland, PhD (1)  ·  Ted C Friedman, M.D., Ph.D. (1)  ·  Weian Yuan, Doctor (1)  ·  Xiaotian Zhang, Master (1)

Results publications

PMID 40958377